About the Ovary Volume Calculator
This calculator estimates ovarian volume using the prolate ellipsoid formula: Volume = Length × Width × Height × 0.523. This is the standard method used in gynecologic ultrasound to quantify ovarian size and is widely accepted in clinical practice and reproductive medicine research. The formula models the ovary as a prolate spheroid and applies the constant π/6 (0.5236) as a correction factor.
Ovarian volume is a clinically meaningful measurement with applications across reproductive endocrinology, oncology, and gynecologic radiology. Unlike uterine volume, ovarian volume varies substantially across the menstrual cycle in premenopausal women — enlarging around follicular development and ovulation before returning to baseline. For this reason, ovarian volume measurements are most reproducible during the early follicular phase (days 2–5 of the cycle) when the ovary contains only small antral follicles and no dominant follicle or corpus luteum.
The most clinically important use of ovarian volume is in PCOS diagnosis, ovarian reserve assessment (combined with antral follicle count and anti-Müllerian hormone), and postmenopausal ovarian evaluation for malignancy. In postmenopausal women, the ovaries undergo progressive atrophy due to cessation of estrogen-driven follicular activity, making any significant enlargement a clinically significant finding that requires systematic evaluation using validated risk stratification tools (O-RADS, IOTA, RMI, ADNEX model).
How to Use This Calculator
Obtain three orthogonal ovarian measurements from transvaginal or transabdominal ultrasound. Select the patient's menopausal status (premenopausal or postmenopausal), enter the three dimensions in centimeters, then press "Calculate Volume." The result will be compared against menopausal-status-appropriate reference ranges.
Length — the longest dimension of the ovary, typically the craniocaudal axis. Measure from the most superior to the most inferior margin of the ovarian parenchyma, excluding obvious large cysts where possible.
Width — the transverse diameter measured perpendicular to the length in the same plane.
Height — the AP (anteroposterior) diameter, measured perpendicular to both length and width. On transvaginal ultrasound, this is typically obtained in the sagittal plane.
Transvaginal ultrasound is preferred over transabdominal ultrasound for ovarian measurement due to superior resolution and proximity to the pelvic organs. In patients who cannot tolerate transvaginal examination, transabdominal technique with a full bladder provides acceptable (though lower resolution) measurement.
Interpretation Guide
| Status | Normal Range | Upper Limit of Normal | Note |
|---|---|---|---|
| Premenopausal | 2.5 – 10 mL | 10 mL | Can vary with cycle phase |
| Postmenopausal | < 2.5 mL | 2.5 mL | Enlarged ovary warrants evaluation |
| Prepubertal | < 1 mL | 1 mL | Use age-specific nomograms |
Ovarian volume in premenopausal women normally ranges from 2.5 to 10 mL per ovary. A volume above 10 mL (in the absence of a dominant follicle or corpus luteum) should prompt consideration of PCOS (if bilateral enlargement with multiple small follicles) or further characterization of any cystic or solid components. Volumes above 20 mL are significantly elevated and warrant prompt evaluation regardless of cycle phase.
In postmenopausal women, normal ovarian volume is typically less than 2.5–3 mL. Any ovary exceeding 8–10 mL in a postmenopausal woman should be considered significantly enlarged and evaluated with further imaging (MRI) or referral to a gynecologic oncology program. The risk of malignancy in an enlarged postmenopausal ovary is significantly higher than in premenopausal women, particularly when solid components, papillary projections, or free pelvic fluid are present.
PCOS Diagnostic Criteria and Ovarian Volume
The Rotterdam consensus (2003) defines polycystic ovarian morphology on ultrasound as ≥12 follicles measuring 2–9 mm per ovary OR ovarian volume ≥10 mL in either ovary (in the absence of a dominant follicle, cyst, or corpus luteum). Meeting this ultrasound criterion, combined with at least one of: oligo/anovulation or clinical/biochemical hyperandrogenism, satisfies PCOS diagnosis under Rotterdam criteria.
Ovarian volume is particularly valuable when follicle counting is technically limited (transabdominal scanning, obesity) or when individual follicles cannot be reliably counted. In such cases, volume ≥10 mL serves as the primary ultrasound diagnostic criterion. Note that the follicle count threshold has been updated to ≥20 follicles/ovary in the 2023 International PCOS Network guidelines, reflecting improved resolution of modern high-frequency probes, but the volume threshold of 10 mL remains unchanged.
When to Be Concerned
Premenopausal: Volume > 10 mL may indicate ovarian cyst, dermoid, endometrioma, or neoplasm. Clinical context and ultrasound morphology guide next steps (e.g., IOTA simple rules, O-RADS scoring).
Postmenopausal: Any ovarian volume > 2.5 mL or solid component warrants further evaluation. Risk of malignancy increases with age and solid architecture. RMI or ADNEX model may assist risk stratification.
Measurement Tips
Measure the ovary in three orthogonal planes on transvaginal or transabdominal ultrasound. The longest dimension (length) is typically the craniocaudal measurement. Exclude large cysts from the solid ovarian tissue measurement when possible. The ellipsoid formula assumes a smooth, regular shape. For PCOS assessment, measure at baseline (early follicular phase) and ensure no dominant follicle or corpus luteum is present before applying the volume criterion.
Limitations & Considerations
The ellipsoid formula is an approximation. Ovaries are not perfect ellipsoids — they can be irregular, contain discrete cysts of varying sizes, or have complex internal architecture. In such cases, the formula overestimates or underestimates the true ovarian parenchymal volume. For ovaries with large dominant cysts, measuring the cyst separately and subtracting from the total volume provides a better estimate of stromal/follicular tissue.
Ovarian volume has substantial physiologic variability across the menstrual cycle. A single measurement is insufficient to characterize ovarian reserve or diagnose PCOS — serial measurements or measurement in the early follicular phase are preferred. Anti-Müllerian hormone (AMH) and antral follicle count (AFC) are more reliable markers of ovarian reserve than ovarian volume alone.
Visualization of ovaries can be technically limited in obese patients, patients with prior pelvic surgery, or those with distorted pelvic anatomy from large uterine fibroids or previous endometriosis. When one or both ovaries cannot be adequately visualized, MRI provides superior ovarian delineation without the ionizing radiation of CT.
References
Pavlik EJ, et al. Ovarian volume related to age. Gynecol Oncol. 2000;77(3):410-412.
Lurie S, et al. Postmenopausal ovarian size by ultrasound. J Ultrasound Med. 1992;11(12):673-676.
Teede HJ, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018;110(3):364-379.
Dewailly D, et al. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 2014;20(3):334-352.
Ovarian-Adnexal Reporting and Data System (O-RADS). American College of Radiology. Available at: acr.org.